May.10
6:49 PM ET
Thursday, 10 May 2012
The "Mad Money" host learns more about this biotechnology company, which he thinks is a great speculative stock. Read More
Jan.09
6:12 PM ET
Monday, 9 Jan 2012
Alkermes expects FDA approval for its new diabetes drug this month, but that might not be enough to make the stock worth buying, trader Guy Adami said. Read More
Topics:Stock Market | Stock Picks
Companies:Alkermes Inc | Eli Lilly and Company | Amylin Pharmaceuticals
News |
COMPANY : Alkermes Inc
Data is a real-time snapshot *Data is delayed at least 15 minutesGlobal Business and Financial News, Stock Quotes, and Market Data and Analysis
© 2012 CNBC LLC. All Rights Reserved.
